Loading

Game Changers Cream of the life sciences sector celebrated at Bionow’s awards dinner

The outstanding contribution made to life sciences by entrepreneur Dr Stephen Little, chief executive of AIM-listed molecular diagnostics company Premaitha Health, was recognised at the 16th annual Bionow Awards.

Dr Little, who led Premaitha through its successful AIM listing in July 2014, has an impressive track record of building biotech businesses and creating value. He is the former CEO of DxS, an innovator in the field of personalised medicine, developing and manufacturing companion diagnostics.

DxS was funded with £3.5m in 2001 and was sold to QIAGEN in 2009 for £85m. Before DxS, Dr Little worked for 20 years in various senior positions in the diagnostic divisions of AstraZeneca and ICI. He holds a PhD from Heriot-Watt University in Edinburgh.

In the highly sought-after Company of the Year category, Keele Science Park-based Cobra Biologics was triumphant. Cobra, an international contract development and manufacturer of biologics and pharmaceuticals, is in the midst of a £15m expansion programme in the UK and Sweden. The company, which manufactures DNA and viral vectors for the gene therapy market, exports 98% of its products.

A £1.4m fundraising by University of Manchester spin-out company Microbiosensor, which develops disposable point-of-care medical devices, was named Investment Deal of the Year, while Peter Chater, a research associate at the University of Newcastle, won in the prestigious Promising Technologist of the Year category.

Celebrating the outstanding leaders and innovators in the life sciences sector in the North of England, the Bionow awards ceremony was attended by more than 400 people at a gala dinner. “The critical importance of the life sciences sector has been acknowledged in the Government’s new Industrial Strategy,” said Dr Geoff Davison, chief executive of Bionow.

“It is hugely pleasing to see new financial support and a clear focus on supporting R&D-focused businesses and encouraging collaboration with the NHS as part of this. Locally, it has been great to see a leading international company like QIAGEN announcing plans to grow its presence in the North – a clear vote of confidence in our sector.”

Dr Davison added: “As ever we had an incredibly strong shortlist and all are to be commended for their innovation in providing solutions which have the potential to be game-changing in the industry. Steve Little is unquestionably one of the most successful entrepreneurs in our sector and he thoroughly deserves recognition for what he has achieved.”

The 2017 awards, which recognised excellence, outstanding achievement and enterprise in a sector that is worth £11bn to the North’s economy, were sponsored by Manchester Science Partnerships, Appleyard Lees, and World Courier.

This article appeared in FutureNorth's 'Life Sciences Edition' in The Times, 26 June 2018. See more online here and download a PDF here.

Sponsors

Winners

Bionow Start Up of the Year Award (sponsored by RSM): ApconiX. A team of world-renowned nonclinical safety experts with more than 300 years of drug discovery and development expertise, committed to advancing drug safety. The team covers all safety disciplines, drug technologies and therapeutic areas. The integrated electrophysiology laboratory generates high quality data in a key area of drug safety research.

Bionow Healthcare Project of the Year Award (TRUSTECH): Sky Medical Technology / James Cook University Hospital South Tees NHS Trust. Project: Reducing the time to surgery for ankle fracture patients. This partnership generated clinical and health economics data which directly lead to the adoption of the gekoTM device for the control of pre-operative oedema in ankle fracture patients demonstrating significant patient benefits, NHS cost savings and an NHS derived health economic business case that is now generating revenues internationally.

Bionow Project of the Year Award (Waters Corporation): University of Manchester. Project: Test for the management and assessment of Inflammatory Bowel Disease. The product offers the first efficient way to manage inflammatory bowel disease (IBD). It provides a non-invasive method to differentiate IBD from IBS, reducing the requirement for endoscopies, providing a robust prognosis for improving symptom management and patient care.

Bionow Product of the Year Award (The Innovation Agency): Crawford Healthcare. Product: KerraContact Ag. A ground-breaking, patented silver wound dressing developed and commercialised in the North West by Crawford Healthcare and available internationally. Clinically proven to be faster acting and more potent than competing products, it is the first and only dressing worldwide to utilise silver in its most active state.

Bionow Technical Service Award (Sponsored by Gateley plc): Cobra Biologics. Technical Service: Delivery of Technical Services related to the process development and manufacture of Plasmid DNA for Gene Therapy Products in clinical trials. Cobra has a global reputation for the production of DNA. Within this technical service offering we develop a process model (USP and DSP), scale up and then produce DNA at either non-GMP (“HQ DNA”) or GMP. Associated services include QC and analytics, fill/finish and final Drug Product Release.

Bionow Business Services Award (Sponsored by World Courier): Innovation Agency. Business Service: Healthcare Business Connect.Providing businesses with access to, and enable collaboration with, the health and social care sector to accelerate the adoption and spread of innovation. The agency helps SMEs to understand the complex systems and commercialise their products / services and support larger organisations to collaborate on large scale pathway transformation projects.

Bionow Promising Technologist of the Year Award (Sponsored by Seqirus): Peter Chater, Postdoctoral Research Associate, Newcastle University. Peter’s achievements include:

  • Developed upper GI model (PCT/GB2014/053449);
  • Led market research to identify need/opportunity for integrated GI model;
  • Secured BBSRC Follow on Funding to develop novel integrated digestion/absorption model;
  • Secured and delivered commercial projects with: FMC Biopolymer, Suntory, Oxford Pharmascience and more;
  • Leading spinout activities.

Bionow Investment Deal of the Year Award (Sponsored by QIAGEN): Microbiosensor Limited. Deal: Series A investment in Microbiosensor by Catapult Ventures and Maven Capital Partners. This deal transforms Microbiosensor Ltd. from a University spin-out company with solid grant funding to a venture-backed business with sufficient capital to CE mark and launch its two lead products. These products have the potential to impact major global medical device markets, and deliver healthcare benefits to vulnerable patient groups, together securing savings of up to £20m pa for each European national healthcare provider.

Bionow Outstanding Contribution Award (Sponsored by Sci-Tech Daresbury): Dr Steve Little, Chief Executive Officer, Premaitha Health plc. Dr Little is a biotechnology entrepreneur, industry pioneer and an expert in the development and commercialisation of molecular diagnostics. A passionate advocate for Manchester and the North West as an ideal location for biotechnology companies, he is a highly respected personality both within the region and throughout the global diagnostics industry. Dr Geoff Davison, CEO of Bionow, commented: “Dr Little is unquestionably one of the most successful entrepreneurs in our sector and he thoroughly deserves recognition for what he has achieved.”

Bionow Company of the Year Award (Sponsored by AstraZeneca): Cobra Biologics. Cobra provides a comprehensive biologics and pharmaceuticals service offering, with multi-functional and experiences project teams nurturing customers’ products from pre-clinical through to clinical and commercial manufacture within three GMP approved facilities.

A not-for-profit membership organisation, Bionow supports the North of England’s burgeoning life sciences sector, which currently includes some 1,000 science and healthcare companies with a combined turnover of around £10.9bn. Its member base includes start-ups and spin-outs as well as well-established businesses. The services it offers to firms include dedicated business support programmes, shared procurement schemes and recruitment and training support.

Report Abuse

If you feel that this video content violates the Adobe Terms of Use, you may report this content by filling out this quick form.

To report a Copyright Violation, please follow Section 17 in the Terms of Use.